Your browser doesn't support javascript.
loading
Safety of ruxolitinib therapy prior to allogeneic hematopoietic stem-cell transplantation for myeloproliferative neoplasms.
Hanif, A; Hari, P N; Atallah, E; Carlson, K-S B; Pasquini, M C; Michaelis, L C.
Affiliation
  • Hanif A; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Hari PN; Department of Hematology and Oncology, Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
  • Atallah E; Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Carlson KS; Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Pasquini MC; Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Michaelis LC; Department of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Bone Marrow Transplant ; 51(4): 617-8, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26726940
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Primary Myelofibrosis Limits: Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms / Primary Myelofibrosis Limits: Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2016 Document type: Article Affiliation country: United States Country of publication: United kingdom